Jose Villegas-Jimenez
Madrid, MD 28041, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Modulation of the Receptor Tyrosine Kinase TIE2/Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells.
Journal: International journal of molecular sciences
Published: December 23, 2025
GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model.
Journal: Journal of biomedical science
Published: July 11, 2025
Corrigendum to "Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases" [Redox Biol. 79 (2025) 103464].
Journal: Redox biology
Published: January 20, 2025
Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases.
Journal: Redox biology
Published: October 25, 2024
NRF2 activation by 6-MSITC increases the generation of neuroprotective, soluble α amyloid precursor protein by inducing the metalloprotease gene ADAM17.
Journal: Free radical biology & medicine
Published: June 11, 2024
The Transcription Factor NRF2 Has Epigenetic Regulatory Functions Modulating HDACs, DNMTs, and miRNA Biogenesis.
Journal: Antioxidants (Basel, Switzerland)
Published: February 14, 2023
Dipeptide Repeat Pathology in C9orf72-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway Imbalance.
Journal: Antioxidants (Basel, Switzerland)
Published: August 23, 2022
Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer's Disease.
Journal: Journal of inflammation research
Published: August 14, 2021
NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS.
Journal: Free radical biology & medicine
Published: May 11, 2021
Can Activation of NRF2 Be a Strategy against COVID-19?
Journal: Trends in pharmacological sciences
Published: May 01, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026